Vancouver-Stem Cells in IBD Research Session

Stem Cells and Miniguts: the newest tools in IBD research

Thursday, March 20th, 2018
7:00pm - 8:30pm

Doors open, 6:30pm
Free Parking
Dr. Martin Stahl completed his PhD in Microbiology at the University of Ottawa under the direction of Dr. Alain Stintzi. His doctoral research focused on mechanisms of infection and pathogenesis of the common gastrointestinal pathogen Campylobacter jejuni. Most notably, this research discovered new metabolic pathways within the bacteria, which impacted its virulence in humans. Following completion of his PhD, he moved to Vancouver to work under Dr. Bruce Vallance at the BC Children’s Hospital Research Institute (BCCHR) as a postdoctoral fellow. His research here focused on innate immune responses to Campylobacter infection and developing new models that could be used to study how this bacteria cause disease in human patients. He has continued working under Bruce Vallance as a research associate, working jointly under a MICTACS between the BCCHR and Vancouver based Stemcell Technologies. This more recent work has focused on developing tools for the cultivation of intestinal stem cells into intestinal organoids as a new model for intestinal research with implications in the field of IBD research.

For more information, please email Teri McGeachie at,
or call 250-213-7761

Register for this education event below!

Are you caregiver to an individual with Crohn's or colitis under the age of 18?:

Location  • 
The Ismaili Centre, 4010 Canada Way, Burnaby, BC V5G 1G8 (Map)
Category  •  edu

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 150 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.